Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data support use of SFP in hemodialysis-dependent patients with CKD

July 7, 2010

Safety and antitumor activity of BMS-754807 reported in phase I trial

July 7, 2010

SBR-759 superior to sevelamer HCI for hyperphosphatemia in Asian hemodialysis patients

July 6, 2010

Brivaracetam dose adjustment not needed for renal dysfunction

July 6, 2010

Genetic variations linked to pancreatic cancer risk

July 6, 2010

Maximum tolerated dose of acadesine identified in chronic lymphocytic leukemia patients

July 6, 2010

Multikinase inhibitor regorafenib evaluated in NSCLC; interim phase I data presented

July 6, 2010

Genetic profiles of patients responding to antihypertensive rostafuroxine identified

July 5, 2010

GPR119 agonist AS-1535907 regulates insulin expression and pancreatic beta-cell mass in vivo

July 5, 2010

Preliminary phase I data on HDAC inhibitor CHR-3996 in advanced solid tumors disclosed

July 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...